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Effective observation and reporting of uncertified/counterfeit drug items demands timely 
identification and dissemination of information to parties’ responsible for consumption, 
prevention, distribution and control of drugs to warrant necessary action in case of a flaw. Tools 
used to identify and report existence of such drug items determine the level of efficiency and 
effectiveness of the exercise. Traditional paper based and rigid computer based reporting 
procedures compromise on completeness, timeliness and correctness of data. This scenario creates 
unprecedented opportunities that researchers can use to improve the current way of identifying 
and reporting counterfeit drugs. This dissertation gives an analysis of the distribution and effects 
of counterfeit drugs to the human population in Kenya and internationally with focus on emerging 
markets. A comprehensive investigation of mobile scanning techniques and existing technologies 
used to track drug items is also covered. Data collection instruments used were through holding 
interviews and observations. Both qualitative and quantitative methods of data analysis were 
employed. Results of the data analysis aided to inform system requirements and design of the 
application. SCRUM, an agile methodology was adopted as the software methodology for 
development of the application. PEPELEZI DAWA, a mobile application was developed as a tool 
to offer an interactive menu where users can scan medication and report counterfeit drug items 
using their mobile devices. A web application was also developed to provide a portal for 
authorized personnel, registered under local drug quality control organisations to; manage users, 
view and edit stored records of drug items and view reports posted by users. System testing was 
done to ensure usability, reliability, completeness and correctness of both developed applications.  
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CHAPTER 1: INTRODUCTION  
1.1  Background of the Study  
According to WHO (2015), a drug is any chemical agent that alters the biochemical physiological 
processes of tissues or organisms. A counterfeit drug as defined by the World Health Organisation (WHO) 
is medicine that is fraudulently mislabeled with respect to identity and source (Essential Medicines & 
Health Products, 2015).  
The problem of counterfeit medication/drug is that the pharmaceutical product is produced and sold with 
the intent to deceptively represent its origin, authenticity or effectiveness. Counterfeit drugs may contain 
inappropriate qualities of active ingredients or none at all. These may be improperly processed within 
the body.  
In Kenya the practice of Pharmacy has been present for the past 50 years. Regulations on the quality of 
medicine was done in the year 1977. The Drug Analysis and Research Unit (DARU), a research unit that 
deals with routine analysis on Pharmaceutical products and market surveillance was developed in the 
same year. In addition the laboratory also carried out consultancy and research into various aspects of 
quality control and good manufacturing practices (Kibwage, 2008).  
  
Figure 1.1: Report on Poor Quality of Drugs (Kibwage, 2008)  
Figure 1.1 shows extracts from selected media newspapers reporting on the poor quality of drug items 
identified in Kenya. Extracts are from the Standard, Kenya Times and Daily Nation Newspapers.  
Currently Kenya has no systematic way of identifying counterfeit drugs. The drugs can be traced in the 
market after reports of having substandard value or observation, while others are encountered in the course 
of quality control. There is therefore need to have a systematic way to identify and monitor counterfeit 
drugs within the Kenyan market.    
2  
  
1.2  Problem Statement  
Quality of medicine is the dimension of output that has the highest impact on consumers including 
pharmaceuticals. For a long time the media has reported on poor quality, non-efficacious and counterfeit 
pharmaceutical products that lack adequate policing. Currently there is no systematic surveillance of drugs 
to establish levels of counterfeit drugs in the Kenyan market.  
  
1.3  Research Objectives  
i) To do a market research on the effects of counterfeit products in Kenya and internationally.  
ii) To determine a contemporary technology used to track and report existence of genuine and counterfeit 
products in the market.  
iii) To develop a mobile device application that can give information on genuine products and flag 
counterfeit products in the market through an appropriate technology.  
iv) To test the effectiveness and efficiency of the developed mobile device application.  
  
1.4  Research Questions  
i) To what extent is the penetration of counterfeit drugs within the Kenyan market and what are its effects 
on the population?  
ii) What are the current technologies used to identify and report existence of genuine and counterfeit 
products in the Kenyan market?  
iii) How can a mobile device application be used to identify and flag genuine and counterfeit goods in the 
Kenyan market?  
iv) What are the findings of testing and evaluation of the developed application?  
  
1.5  Scope of the Study  
For purposes of creating a model mobile application, the case study will be conducted in Nairobi, Kenya. 
The proposed study will be customized for the Kenyan market. The developed application will implement 
the Android Operating System as the underlying software platform targeting users with access to data 
enabled mobile devices embedded with a camera.  In the proposed study the researcher will only deal with 
factors affecting software development of the prototype and not mass printing of QR-Codes that need to 
be attached to specific drug items.  
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1.6  Significance of the Study  
The significance of this dissertation is to help solve a real life problem. The Kenyan market is currently 
flooded with a wide range of counterfeit drugs. Drug users are therefore at risk in using such drugs as they 
are harmful to their health or ineffective for treatment. It is therefore mandatory that a solution be found 
that will make it easy for users to identify and report counterfeit drugs upon purchase.  
Development of a mobile based application solution is one such way that is deemed to easily identify 
and report counterfeit drugs.  The mobile application will be used by retailers, consumers and KEBS 
officials within different counties in Kenya. The solution is scalable and can be customized and 
replicated to other countries.   
A secondary benefit to the solution is that data can be collected and analysed further. The data can be used 
to generate different reports such as:  
i) To know more about the distribution and usage of drugs in the Kenyan market.  
ii) To keep an account of key areas where certain drugs are acquired and sold.  
iii) To study the usage patterns of specific drugs by the population. Such as the availability or 
preference to use certain drugs by the populace of an area.  













CHAPTER 2: LITERATURE REVIEW  
2.1  Introduction  
The U.S. Food and Drug Administration (FDA) terms Counterfeit medicine as fake medicine which may 
be contaminated or contain the wrong or no active ingredient. The drugs may also have the right active 
ingredient but at the wrong dose. The FDA classifies counterfeit medicine as illegal and harmful to human 
health (Counterfeit Medicine, 2015).  
In Kenya Counterfeit drugs are identified as those that are deliberately and fraudulently mislabeled with 
respect to their identity or source. Generic drugs are those that are produced and distributed without patent 
protection. They are a chemically equivalent, lower-cost version of a brand-name drug. Both drug 
classifications have the same active ingredient, dosage, safety, strength, usage directions, quality, 
performance and intended use (Generic versus Brand Medication, 2014).  
Countries with weak drug regulations and enforcements, unregulated markets, scarcity or erratic supply 
of basic medicines and unaffordable drug prices are prone to counterfeiting becoming more sophisticated 
including Kenya. The Kenyan market has been flooded with counterfeit drugs making it possible for any 
individual to come across medicine that is packaged correctly in the form of capsules, syrups or tablets 
but containing wrong ingredients that maybe toxic.  
  
2.2  Effects of Counterfeit Drugs on Humans  
Chemical substances taken as drugs have diverse pharmacological effects on the human biological system. 
Some of the effects are contraction of muscles, secretions from glands, alterations of hormonal levels, 
modulation of nervous activities and many other physiological body changes (Erwin , 2014).  
Third world countries due to meagre foreign exchange earnings are short of financial muscle to buy drugs 
leading to restrictions in importing large quantities of quality drugs. Issues related with modern drugs in 
third world countries include quality assurance, drug availability and the stability of drugs in the tropics 
(Ahmed, 1985).  
Governments are faced with the challenge to guarantee quality of drugs being imported due to lack of 
skills and expertise to ensure that drugs are genuine and can be well preserved it the tropical climate 
without deteriorating (Ahmed, 1985).   
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Counterfeit drugs have adverse effects on the health of humans (Akunyili, 2005). Regular use of such 
drugs can lead to therapeutic failure or drug resistance and in some cases leading to death (Counterfeit 
Medicine, 2015). Some of the characteristics of fake drugs include:  
i) Unintended Effects; counterfeits may substitute a drug for another. An example is whereby insulin 
can be found to have been substituted for a more expensive injectable drug. It is evident that 
counterfeiters emptied bottles of Zyprexa, a drug used to cure schizophrenia and acute bipolar 
mania, and replaced them with white tablets printed with the word “Aspirin”.  
ii) Toxic Effects; some counterfeit drugs may contain lethal ingredients that when ingested or injected 
can cause health problems. An example is a recent counterfeited drug called Procrit, important 
drug for Cancer and Acquired Immune Deficiency Syndrome (AIDS) patients contained nonsterile 
tap water which causes an infection in the bloodstream when used.  
iii) Ineffective Treatments; other fake drugs contain active ingredients but are sub potent. Others will 
try and copy the real drug but still pose safety risks because they are not formulated in a way that 
achieves the right therapeutic levels in the patient’s blood.  
iv) No active ingredients; some drugs have no active ingredients. A counterfeit version of Serostim, a 
growth hormone used by patients with AIDS was found to contain no active ingredients hence 
leading to therapeutic failure and deterioration of health.  
v) Fake Labels; counterfeiters have made perfect the art of duplicating packaging and labeling of 
legitimate prescription drugs. It requires thorough inspection to be able to identify differences 
between counterfeit and legit drugs.  
All in all patients at the minimal face the risk of therapeutic failures or deteriorating health issues that a 
drug was intended to treat. Criminals engaging in counterfeiting practices have disregard for the wellbeing 
of ill patients and the safe practices of legitimate companies and individuals involved in the distribution 
of prescription drugs.  
A number of cases of fatalities have been reported in many countries. According to Diaz (2006) a healthy 
22 year old woman living in Viedma Argentina had been diagnosed with mild anaemia caused by 
insufficient iron in her blood. She needed iron injections. In December 2004, she fell sick and died of liver 
failure after receiving a 7th out of 10th injection treatment. The medicine authority of Argentina (ANMAT), 
after a postmortem concluded that her cause of death was from a highly toxic counterfeit drug. Authorities 
were however unable to determine the source of the counterfeit product due to fabricated paper work. A 
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thorough investigation was done. Majority of the counterfeit drugs in the market were recovered with the 
persecution of four individuals involved in the production of the lethal drug. Due to the highly fragmented 
distribution system the recall exercise was not 100% successful. In May 2005 one woman died and another 
survived on the same drug. The survivor was a 22 year old pregnant woman who gave birth to a 26 week 
premature baby. To date, Argentinean law doesn’t consider counterfeiting of medicine a crime (WHO, 
2006).  
  
2.2.1 Documented Cases of Fatalities Caused by the Use of Counterfeit Drugs  
Niger Republic – in 1995 during a Meningitis epidemic more than 50,000 individuals were inoculated 
with fake Meningitis vaccines resulting to the death of nearly 2,500 individuals (WHO, 2006).  
Haiti – in 1995, 89 infants died due to the consumption of Paracetamol Syrup prepared with a toxic 
chemical called, Diethylene Glycol. Diethylene glycol is a clear, odourless, viscous liquid with a sweetish 
taste. It is used as an industrial products but has also been prominent in mass poisonings dating back to 
the 1930's (Beasley, Temple, Slaughter, & Schep, 2015).  
Enugu State, Nigeria – in 1989 several children were killed in the University of Nigeria Teaching  
Hospital due to poorly compounded Chloroquine Syrup. It is believed that many more died in the early  
1980’s. No statistics were recorded partly due to unreported death cases (Diaz, 2015).  
Ibadan and Jos, Nigeria – in 1990, 109 children died in Ibadan and Jos after consuming Paracetamol 
cough syrup laced with the toxic Ethylene Glycol solvent instead of Propylene Glycol. The incident had 
previously occurred more than 50 years ago in the United States of America (USA) (Diaz, 2015).  
India – in 1998, 30 infants died due to the consumption of Paracetamol Syrup prepared with a toxic 
chemical called, Diethylene Glycol (Diaz, 2015).  
Cambodia – in 1999, about 30 individuals died after taking counterfeit anti-malarial drugs prepared with 
Sulphadoxine - Pyrimethamine, an older less effective anti-malarial. The drugs were sold as artesunate. 
Approved by the FDA, artesunate is a non-oral drug used to treat severe Malaria in the USA (Diaz, 2015).  
  
  
2.3  Reported Cases of Counterfeit Drugs in Third World Countries  
Below is a list of reported cases of counterfeit drugs in third world countries (Essential Medicines & 
Health Products – Counterfeit Medicines, 2015).  
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Angola – in 2004 a report by the National Department of Intellectual Copyright Crime of the Economic 
Police stated that approximately 70% of drugs used by the Angolan population were counterfeit.   
Kenya – in 2005, a random survey was conducted by the National Quality Control Laboratories (NQCL) 
and the Pharmacy and Poisons Board. Results showed that almost 30% of drugs in Kenya were counterfeit. 
Counterfeiters were so crafty that some of the drugs used were no more than chalk and untreated water 
sold as legitimate pharmaceutical products. The Kenya Association of Pharmaceutical Industry also 
reported that counterfeit products account for approximately $130 million annually in sales. Figure 2 
below shows netted counterfeit drugs valued at approximately KES 5 million being burnt in Nairobi, 
Kenya.  
Russia – in 2006 the Federal Service for Health Sphere (FSHSS) reported that 10% of all drugs in the 
Russian market were counterfeit. Other sources indicated that the results were higher.  
Dominican Republic – in 2005 the Republic’s public health Department reported that 50% of the 
pharmacies in the country operated illegally and 10% of medicines arriving in the country were fake. 
Medicines found in some of the pharmacies were found to be over 10 years old.  
Indonesia – in 2005, the International Pharmaceutical Manufacturers Group (IPMG) estimated that 
pirated drugs constituted 25% of Indonesia’s $ 2billion pharmaceutical market.   
  
Figure 2.1: Destruction of Counterfeit Drugs in Kenya (Business Daily Africa, 2013)  




Figure 2.1 shows burning of counterfeit drugs estimated to be valued over KES 5 million in Nairobi 
Kenya. A report by the Kenyan Association of Pharmaceutical Industry (KAPI) estimates that counterfeit 
pharmaceutical products account for approximately KES 12.7 billion annually in sales as at the year 2010 
(Ciuri, 2015).  
  
2.4  Major Challenges in Combating the Use and Distribution of Counterfeit Drugs  
Some of the challenges faced in combating the use and distribution of counterfeit drugs as reported by 
Markey & Liang (2011) are:  
i) Lack of proper regulations and law enforcements in many developing countries encroaches in 
the quality, safety and efficacy of locally manufactured and imported medicines making them 
substandard.   
ii) Smuggling of counterfeit drugs is also prevalent in developing countries with some acting as 
zones for exporting or re-exporting counterfeit drugs.  
iii) In an attempt to avoid detection counterfeiters engage in collaborative schemes to disguise 
their activities. Such activities include; establishing fake businesses and companies, 
exploitation of weaknesses in border controls especially when governments reduce border 
inspections in an attempt to promote international trade, falsifying documents to obtain 
essential active pharmaceutical ingredients as well as manufacturing products that emulate 
genuine products.  
iv) Policy makers in governments perceive drug regulations as unnecessary barriers to trade and 
should be reduced to the minimum (Mackey & Liang, 2011).  
  
However, it should be noted that counterfeiting of medicine is a lucrative business due to the continued 
high demand for medicines and low production costs. The seemingly high price of legit medicine and the 
steep price difference between identical fake products creates and incentive for consumers to seek 
medicine outside legal supply chain systems. Sometimes official supply chains fail to reach many poverty 
stricken communities and rural areas. It is these major factors that contribute to creating markets for 




2.5  Control of Drug Manufacturing and Distribution in Kenya  
The practice of pharmacy has been in existence in Kenya for over fifty years. The need to have a body to 
regulate quality of medicine for use by the public began in the year 1977 (Kibwage, 2008). The Pharmacy 
and Poisons Board (PPB) within the Ministry of Health was established in 1982 with the following 
mandates (Maitai, et al., 1982):  
i) Drug Market Authorisation.  
ii) Market surveillance of medicines circulating locally.  
iii) Quality control facilities to support market surveillance and authorization.  
  
2.5.1 Drug Market Authorisation  
This is the process of auditing application dossiers for drug registration by an expert committee. Quality 
of the drug may also be determined through laboratory testing. The process aims at creating Efficacy, 
Safety and Quality through appreciation of good manufacturing practices. Once achieved, Market 
Authorisation allows a product to be released to the market (Maitai, et al., 1982).  
Release of drugs in the market creates competition of generic and innovator products which in turn attracts 
counterfeiting of drugs. Manufacturers have therefore been tasked by regulators to provide information 
on product’s new uses, adverse effects, relocation of factory sites, processes or production and ingredients.  
Drug registration must be renewed every five years in Kenya (Kibwage, 2008).  
  
In the years 1982 to 2008, the average number of drugs registered in Kenya was about 700 annually with 
about 20,000 drugs being registered in the whole range of years (Kibwage, 2008). Table 2.1 shows the 
total number of registered drugs and those registered in 2007.  
  
Table 2.1: Total Number of Registered Drugs in Kenya in 2007  
Registration status   Number of products   
Drugs registered between 1982 to 2007      19,570   
Newly registered drugs in 2007      643   
Drugs re-registered in 2007      1,126    
  
Source: Pharmacy and Poisons Board, Ministry of Health (200 (KEBS, 2014)7).  
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2.5.2 Drug Quality Control  
Laboratory testing creates a strong statement when confirming the quality of drugs through a regulatory 
body of certain medicines within a market under its area of jurisdiction. Two laboratories, the Drug 
Analysis and Research Unit (DARU) and the National Quality Control Laboratory (NQCL) are mandated 
to carry out quality control functions in Kenya. The Drug Analysis and Research Unit (DARU) is a 
premier laboratory in Kenya established in the Department of Pharmaceutical Chemistry at the College 
of Health Sciences (College of Health Sciences, 2016). Samples are received from local industries, private 
practitioners, non-governmental organisations, regulatory authorities and hospitals. Drugs are then 
analysed under specification of the European Pharmacopeia, British Pharmacopeia and the United States 
Pharmacopeia. Drugs not subject to official compendia are analysed with accordance to the 
manufacturer’s specifications and methods (Kibwage, 2008).  
  
2.6  Theoretical Review  
Numerous Information Communication and Technology (ICT) systems have been designed with a bias 
towards social aspects and are impervious to learn (Lyytinen and Damsgaard, 2001). Often they require 
advanced skills and proficiency during implementation, operation and adorption (Attewell, 1992; 
Andriessen, 2003; Lyytinen and Damsgaard, 2001; West et al., 2007).  
According to Bagozzi et al. (1992), ICT systems need to be better understood in the whole adoption 
process as is the role of learning their use. Inadequate ability to learn and use systems can hamper adoption 
and implementation of a potentially productive system. It was therefore mandatory to learn the implication 
of research theories and how they can be applied in implementing and adopting ICT in the area of 
management and business.  
This dissertation was supported by two theories namely: Technology Acceptance Model (TAM) theory 
and Theory of Reasoned Action (TRA).  
  
2.6.1 Technology Acceptance Model  
This model is concerned with ICT usage behaviour and what causes potential adopters to accept or reject 
use of information technology. Based on the TRA two theoretical constructs were used: Perceived  
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Usefulness; referring to the degree to which users believe that using a system will enhance job 
performance. Perceived Ease; referring to the degree which users perceives a system to be free of effort 
(Davis, 1989).  
  
2.6.2 Theory of Reasoned Action  
This theory makes the assumption that a user’s behaviour is determined by the intention to perform an 
action. The intention is further determined by the user’s attitude and perception from individuals, other 
than him, towards the user’s behaviour (Fishbein & Ajzen, 1975).  
  
2.7  Empirical Review  
This section will give an overview of challenges faced by regulatory bodies, in this case, The Kenya 
Bureau of Standards (KEBS) and how they cope with the problem of counterfeited items.   
  
2.7.1 The Kenya Bureau of Standards  
Kenya has a legal framework and mechanism to determine that all commodities imported or manufactured 
comply with certain standards. The Standards Act. Section 4 (1) (c & d) of the Act establishes KEBS as 
the main regulatory body whose functions are, inter alia “to make arrangements or provide facilities for 
the examination and testing of commodities and any material or substance from or with which and the 
manner in which they may be manufactured, produced, processed or treated” and “to control, in 
accordance with the provisions of this Act, the use of standardization marks and distinctive marks”, 
respectively (Laws of Kenya, 2012).  
  
2.7.2 Challenges Facing KEBS in Combating Counterfeit Trade  
Key areas that pose as a challenge to KEBS in conducting its business normally fall under the following: 
Administration, Counterfeit Intelligence, Legal and Supply Chain. Specific challenges encountered under 
key areas mentioned above were (Kenya Bureau of Standards, 2009):   
i) Lack of complaints by customers regarding ineffectiveness of items.  
ii) Lack of proper international support in combating counterfeiting of 
items.   
iii) High levels of poverty and ignorance. 
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iv) Weak laws governing counterfeit items.  
v) Lack of resources (human and financial).   
v) Lack of state of the art equipment and procedures in testing products.  
vi) Porous borders acting as transit corridors for entry of counterfeit items into the 
country.  
vii) Lengthy legal process before disposing of cases relating to counterfeit items.   
ix) Lack of well trained staff as is required by international standards.   
  
This dissertation undertook to solve the problem that specifically deals with supply chain, management 
and distribution of drug items. The specific problem addressed was the inability of consumers to detect 
and report uncertified drug items. A big challenge that KEBS faces is the use of fake Standardisation 
marks (KEBS, 2014).   
KEBS administers a conformity assessment program on behalf of the government based on Article 5 of 
WTO-TBT (World Trade Organization/ Agreement on Technical Barriers to Trade) agreement on 
regulated goods in Kenya. This is to minimize risk of substandard and unsafe goods entering the Market. 
KEBS provides a list of classifications of products with unique codes that should undergo the verification 
process. Figure 2.2 shows the KEBS code chart of PVoC regulated items in the Kenyan market (KEBS, 
2014).  
  




KEBS utilizes marks that are attached to certified products to visually show that products have been 
certified. Some examples are as follows:  
  
The Mark of Excellence (Diamond mark)  
A voluntary mark based on excellent performance of products. This  
  
is superior to all other quality marks.  
Figure 2.3: The Mark of  
Excellence (KEBS, 2014)  
   
  
The Standardisation Mark (SM)  
This mark is mandatory for all locally manufactured products.  
  
Figure  2.4:  The  Mark  of  
Standardisation (KEBS, 2014)  
   
  
2.7.3 Technological Solutions KEBS is undertaking to curb the Problem  
Currently KEBS officers are equipped with technology that aids them in identifying whether items have 
been certified or not. The technology consists of palm tops used to detect counterfeits. Officials input the 
product’s name and information about the item’s certification then the status pops up on the mobile device. 




2.8  Current Technologies to Check the Use and Distribution of Counterfeit Drugs  
The researcher reviewed current technologies used to verify and report the existence of counterfeit drug 
items in Kenya and internationally.   
  
2.8.1 MPedigree  
MPedigree is an African based startup founded in the year 2007 by a young Ghanaian by the name Bright 
Simons. The company sells software that manufacturers use to label individual packs of medication with 
a random 12-digit code. The code is hidden under an easily scratch panel, similar to an airtime scratch 
card that is attached on the medication packaging. When purchasing medicine the buyer can text the code 
to MPedigree for free getting an instant response confirming that the product is authentic. A report by the 
Bloomberg Business magazines states that currently MPedigree has produced labels on more than 500 
million drug packets (Yepoka, 2015).  
 
Figure 2.5 shows a verification process via SMS of a drug item with a label from MPedigree.  
  




A Architectural Structure of MPedigree  
Figure 2.6 represents an illustration of the architectural structure of MPedigree. Through an active and 
existing GSM network in Ghana, end users can query for information of specific products through product 
codes, MPedigree Network (2013). Branded medicine from manufacturers are approved and registered at 
a central repository managed by MPedigree.  
  





B Challenges experienced by MPedigree  
A major challenge reported by MPedigree is when users try to manipulate working of the system. In one 
complaint a single authentication code had been checked 1500 times more than two days. It was later 
realized that someone had taken a genuine code and made thousands of its copies and attached them to 
counterfeit morning after pills somewhere in the neighboring country Nigeria. A similar incident had 
occurred previously. MPedigree was able to locate a warehouse full of counterfeit malaria medication in 
the previous incident. To counter the problem MPedigree started calling users who tested the fake code to 
find out where they got the drug. This was in an attempt to locate the source so as to alert regulators and 
law enforcers.   
Customers may sometimes experience delays in responses to queries through SMS’s taking too long to be 
delivered. This may be attributed to clogging on the network within a particular area or unforeseen 
technical hitches with network devices such as transponders.  
MPedigree’s mobile application is restricted to SMS and GSM platforms. This means it doesn’t support 
data enabled devices. This is a major setback to the future of the application as mobile devices are now 
developed to be fully dependent on data based applications and systems. 5G technology which is a data 
based communication technology is expected to be standardized by the year 2020 (Sutton & Tafazolli, 
2015).   
  
C MPedigree’s Competitive Advantage  
MPedigree’s competitive advantage is in its geographic location. It is based in a region worst hit by 
counterfeit drugs. This ensures that its mandate, which is to fight counterfeit drugs, always receives 
welcome from governments and other institutions concerned with the well-being of its populace. 
MPedigree’s long-term vision is to be the most trusted repository of information about consumer goods 
(Yepoka, 2015).  
  
2.8.2 PharmaSecure  
PharmaSecure is a startup mobile based solution founded in the year 2007 by Nathan Sigworth. The 
company is based in Lebanon – New Hampshire and Gurgaon – India.  The company helps drug 
companies’ combat counterfeit medication in the developing world. The startup company partners with 
pharmaceutical companies throughout India to print serial numbers on drug bottles. Consumers of the 
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drug items are then given the option of texting the serial numbers to a provide mobile phone number to 
verify that the medication is authentic. Other than that valuable information it given out to pharmaceutical 
companies about their customers. Pharmaceutical companies pay a premium to get the service (Lapowsky, 
2012).  
  
2.8.3 Sproxil  
Sproxil operates by placing a label with a scratch-off panel on all its protected products. Just as the above 
mentioned mobile based applications, consumers scratch off at the point of purchasing a drug to reveal a 
unique code that can only be used once. The code is sent via Short Message Service (SMS) or a mobile 
application to a specific short code. The consumer will receive a reply instantaneously indicating that the 
product purchased is genuine or uncertified. Figure 2.7 shows an image of the response from a drug item 
verified by Sproxil Mobile phone application.  
   
Figure 2.7: Sproxil Drug Process (Sproxil, 2015)  
  
In July 2011 it was reported that the Kenya’s Pharmacy and Poisons Board (PPB) adopted Sproxil’s SMS 
based anti-counterfeiting system however, there is no evidence showing existence of the application in 
the market. Sproxil claims that to date it has processed over 14million verifications from consumers 




A Sproxil’s Business Operations Model  
Figure 2.8 shows an illustration of Sproxil’s Business Operations Model. Pharmaceutical companies, drug 
manufacturers and distributors are the main customers of Sproxil.  
  
Figure 2.8: Sproxils Business Operations Model (Sproxil, 2012)  
  
2.9  Scanning Technologies  
There are a number of scanning technologies that are in use today, some dedicated device scanning or 
mobile based scanning. Listed below are mobile device scanning technologies used synonymously with 
mobile devices. A mobile device could be used in place of a dedicated scanning device having an inbuilt 
reader that transmits radio frequencies over a tag or a mobile device camera to scan over barcode/QRCode.  
  
2.9.1 Mobile Based Scanning Technologies  
These scanning technologies include scanning processes that rely on a user physically scanning items 
using a smartphone held by hand. Some of these technologies include: QR-Code Scanning, RFID 




A QR-Code Scanning  
QR-Code is an abbreviation for Quick Response Code. It is a type of Matrix Barcode or two dimensional 
Barcode designed initially for the Automotive Industry in Japan. A barcode is defined as a 
machinereadable optical label containing information about an item that it is attached to (Ullrich, 2011).    
 
Figure 2.9 shows an example of a QR-Code.  
  
Figure 2.9: QR-Code (Denso Wave, 2014)  
   
QR-Codes can be used on a variety of mobile device operating systems. The mobile devices support URL 
Redirection that allows the codes to send metadata to existing applications on the device. Many purchased 
of free mobile based applications come with the ability to scan the codes and hard-link to external URLs 
(Law & So, 2010).  
A QR-Code is a kind of two dimensional symbol developed by Denso Wave (a division of Denso 
Corporation). Figure 2.10 shows the comparison between a QR-Code and a traditional Bar Code. This 
technology was launched in 1994 with the aim of being a symbol to be easily interpreted by a scanner 
(Denso Wave, 2014).  
  
Figure 2.10: Comparison between QR-Code and a Traditional Barcode (Denso Wave, 2014)  




QR-Codes use four Standardised encoding modes namely; numeric, alphanumeric, byte/binary and kanji 
to store data efficiently. They consist of black square dots arranged in a grid the shape of a square on a 
white background. These dots can be read by imaging devices such as cameras and dedicated scanners. 
The image captured is then processed using Reed-Solomon error correction until it can be interpreted 
appropriately. Data is extracted from the images patterns present on both its vertical and horizontal 
components.  
The amount of data stored in a QR-Code symbol depends on the datatype, version and error correction 
level. Maximum storage capacities for the codes occur for 40-L symbols (Version 40, error correction 
level L), (Stechz, 2012).  
  
Error Correction  
This process uses code-words that are 8 bits long. Reed-Solomon error correction algorithm is used with 
four error correction levels. A higher error correction level translates to a low storage capacity. Table 2.2 
lists approximate error correction capabilities at each of the error correction levels (Plank, 1997).  
  
Table 2.3: Approximate Error Correction Capabilities at each level  
Error Correction Level  Code-words that can be restored  
L (Low)  7%  
SM (Medium)  15%  
Q (Quartile)  25%  
H (High)  30%  
  
Uses of QR-Codes  
QR-Codes are more commonly used in consumer advertising. Ideally, a smartphone is used as the code 
scanner which converts the code into useful data such as a standard URL for a website. This removes the 
need for a user to type the URL into a web browser.  
QR-Codes are also used other applications such as Commercial tracking of commodities; Entertainment 
and transport ticketing, product/loyalty marketing and In-store product labeling.  
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Many of the mentioned applications target mobile phone users (via mobile tagging). After scanning 
QRCodes users may receive a message, compose an e-mail or test message, add a virtual card contact to 
their device or open a URL. QR-Codes may also be linked to a location to track where a code was 
originally scanned. An applications scanning the code receives the geo information by using GPS and cell 
tower triangulation. The URL encoded in the QR-Code may itself be associated with a location (Geo 
Tagged QR Codes, 2011).  
Some advantages of using QR-Codes are (Johnson, 2011):  
i) Ease of use; the code can be added to any kind of product making it versatile for marketers.  
ii) Can be used for a variety of uses.  
iii) Traceable; through web analytics and unique codes placed on different products valuable 
information can be acquired from the behaviour of the market to the products.  
iv) Easy way to direct mobile users to online/web content; as the name suggests, a quick response 
mechanism saves the time and effort of a use typing in a URL or an SMS short-code.  
v) The technology is appealing to mobile users; due to it being rather new mobile users have the 
urge to scan and find out where it leads. Of course through time its novelty will wear off (Charlton, 
2011).  
vi) Cost effective; QR-Codes can be created at no cost.  
vii) Some disadvantages of using QR-Codes are:  
viii) Users need to download a QR-Code scanner/reader; mobile users usually have to 
download a (free) QR-Code reader which limits many.  
ix) Scanning can be a long process; Low INTERNET speeds can render the scanning process very 
slow. A user may not be patient enough to wait for the outcome (Charlton, 2011).  
x) Lack of awareness; a small percentage of mobile users are aware that QR-Codes can be useful 
than to be redirected to a website.  
  
B Radio Frequency Identification (RFID) Scanning  
RFID is the use of electromagnetic fields to transfer data. This usually is for the sole purpose of 
automatically identifying and tracking tags attached to objects. The tags contain electrically stored 




Figure 2.11: An RFID Tag (Kevin & Felon, 2007)  
  
Figure 2.11 shows an RFID tag specifically designed for fitting in a luggage and large parcel for tracking.  
  
Basic working of an RFID tag  
Below are the basic workings of an RFID tag as reported by RFID Journal (2005).  
i) Data stored within an RFID tag’s microchip waits to be read.  
ii) The tag’s antenna receives electromagnetic energy from an RFID reader’s antenna.  
iii) Using power from its internal battery or power harvested from the reader’s electromagnetic field, 
the tag sends radio waves back to the reader.  
iv) The reader picks up the tag’s radio waves and interprets the frequencies as meaningful data (RFID 
Journal, 2005).  
  
Types of RFID tags  
These are less expensive tags to produce and can be made small enough to fit on almost any product. 
Frequencies transmitted by RFID tags can be adjusted to avoid interference with other electronics or RFID 
tags and readers in the form of tag interference or reader interference.  
RFID tags can make use of RFID systems called Time Division Multiple Access (TDMA) to make sure 






Uses internal battery to power its circuit also uses its battery to broadcast radio waves to a reader. Contains 
more hardware than passive RFID making it more expensive than passive. Reserved for costly items that 
are read over great distances.  850 to 950 MHz can be read about 100 feet away (Violino, Farm Harvests  
RFID’s Benefits, 2004).  
  
Semi-passive  
Uses internal battery to power its circuit. Relies on the reader to supply its power for broadcasting. 
Contains more hardware than passive RFID making it more expensive than passive. Reserved for costly 
items that are read over great distances.  850 to 950 MHz can be read about 100 feet away (Violino, Farm  
Harvests RFID’s Benefits, 2004).  
  
Passive  
Relies entirely on the reader as their power source. These tags are read up to 20 feet away and they have 
lower production costs, meaning they can be applied to less expensive merchandise. Generally these tags 
are manufactured to be disposable, along with the disposable consumer goods on which they are placed 
e.g. RFID tag on a bottle of shampoo (Kevin & Fenlon, 2007).  
Another factor that influences the cost of an RFID tag is data storage. There are 3 storage types: readwrite, 
read-only and WORM (write once, read many).  
Some of the common uses of RFID are:  
  
Asset tracking  
This is the most common way of implementing the technology. Companies have been known to put RFID 
tags on assets that are often stolen, underutilized or are hard to locate when needed. A company such as 
Air Canada saves millions each year by tracking food carts used at airports around the world. RFID has 
benefited the company by ensuring there are fewer loses of carts and less time and money spent taking 







In manufacturing RFID is used to track parts and work in process to reduce defects, increase throughput 
and to manage the production of a variety of versions of the same product. A company by the name 
Johnson Controls based in Milwaukee, USA is a supplier of car and truck interiors. The company supplies 
dashboards, seats and other components three big automakers. Johnson controls later installed a system 
to track different versions of truck and car seats it supplied. The system was a success as it proved to be 
very extremely accurate in tracking their commodities (Collins, 2013).  
  
Supply Chain Management  
RFID is increasing being used to companies to track shipments among supply chain partners. In other 
instances RFID has been used to automate parts of the supply chain within a company’s control. Some 
benefits associated with such systems are increased throughput, reduced shipping error and reduction in 
labour costs (Violino, Farm Harvests RFID’s Benefits, 2004).  
  
Some advantages of RFID are:  
i) Tags can be read at a faster rate as compared to other technologies such as 
barcodes (Wireless Technology Advisor, 2014).  
ii) Processes can be run with minimal human intervention. iii) Frequencies can be 
read from greater distances (RFID vs Barcodes, 2012). iv) No need to position 
the scanner and tag in a straight line of sight (Piasecki, 2012). v) Tags have 
read/write capabilities, meaning they can be customized.  
vi) Have high capacities of storing data.  
vii) Are highly secure; data can be encrypted, password protected or permanently deleted.  
  
Some disadvantages of using RFID are:  
i) Systems are often more expensive than systems such as QR-Code and Barcodes (Wireless 
Technology Advisor, 2014).  
ii) In cases where two signals from different readers overlap there can be a dead zone. This is 
where there a reader collision occurs causing no response from readers.  
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iii) A Tag collision may occur when numerous tags in the same area respond to a reader at the 
same time (RFID vs Barcodes, 2012).  
iv) Tags are may appear larger than labels such as Barcodes or QR-Codes.  
v) Tags are programmed to operate on specific applications (Wireless Technology Advisor, 
2014).  
vi) Readers use up lots of energy when picking up information through metal or liquid.  
vii) Reader collision can occur where two signals from different readers overlap and the tag is 
unable to respond to both (RFID vs Barcodes, 2012).  
  
2.10 Gaps and Limitations on Existing Technologies  
Existing techniques used to scan and verify products to find out whether they are genuine or uncertified 
revealed that the only automated techniques available to the public in Kenya is through the use of SMS, 
QR-Code and RFID.  
SMS requires that a user scratch off a hidden code/serial number after purchasing a product. The 
code/serial number is then sent via SMS to a specific short code that extends its service to a database for 
verification. The user will then receive an instant response confirming that the product is authentic or fake.   
This approach is limiting since a user will have to purchase a product before scratching off to reveal the 
hidden code. Once a user purchases an item and identifies that it is counterfeit he/she has no option of 
returning the fake item but to purchase another. The process of acquiring a short code to send SMS’s is 
also quite expensive. Another setback is seeding for funds to make such a service free to the public which 
can be time consuming. So far the SMS verification approach has been made available only to large 
multinational companies that have the financial muscle to implement the system for tracing their own 
products.  
According to Xhiang, et al. (2004) the limitation of using RFID tags is that the approach would be 
beneficial when focusing on an already secure supply chain. The research location of study is in a third 
world country struggling to have an efficient legal framework to control and manage entry of counterfeit 
drugs into its borders. A better solution is the development of a system that will aid in detecting illegal 
drugs that have reached their destination. RFID tags are also quite expensive to implement in this region 
due to the complex manufacturing process and maintenance.  
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The use of QR-Codes in identifying and reporting the existence of counterfeit or uncertified products in 
Nairobi - Kenya bridges the gap and limitations reflected in SMS and RFID use. Technology is moving 
towards digitization of mobile communication. Implementation of QR-Codes in future will be cheaper for 
the government and local manufacturers to implement compared to RFID tags and the use of SMS as a 
media of communication. QR-Codes also eliminate the need of having a mobile phone carrier route 
communication through its servers. This information can be sent directly to servers located in offices of 
regulatory bodies such as the Kenya Bureau of Statistics and the Pharmacy and Poisons Board enabling 
devolution and easy management of services. Furthermore we now have INTERNET enabled phones 
offered at the same price as features phones making them available to a large population. With the 
initiative of the government in ensuring public users in  major counties including Nairobi and its 
environment acquire free INTERNET services by December 2015 only puts the research at an advantage.  
  
2.11 Proposed Solution from the Literature Review  
Currently there is no systematic way of identifying counterfeit/registered drugs in Nairobi, Kenya.  
Methods used to identify counterfeit drugs are by tracing them in the market after reports of having 
substandard value, by observing the drug’s physical appearance, while others are encountered in the 
course of quality control.   
The mentioned approaches of identifying counterfeit drugs have been used extensively for tracking 
commodities in first world countries especially in supply chain management through the use of RFID.  
This however doesn’t add value when trying to identify and report counterfeit products that are already in 
the market as the case is in third world countries.  
The use of SMS is the only practically available technology for addressing the problem of identifying and 
reporting counterfeit/uncertified drug items in emerging markets more so in Kenya. Unfortunately, the 
cost of accessing such a service is still too high for many startup companies.   
The use of QR-Code predominantly stands out as an approach that could help alleviate the problem by the 
public both presently and in future. With the availability of cheap INTERNET enabled mobile devices to 
the public the approach greatly favours this research in making its goals achievable.  
This research is therefore justified in helping to alleviate the problem of systematically identifying and 
reporting the existence of counterfeit drugs in Nairobi, Kenya given the costly and highly restrictive 
alternative technologies mentioned. A mobile device, QR-Code reader, dedicated mobile based 
27  
  
application and QR-Codes all combined bring about benefits such as accountability, compliance, 
productivity, accuracy and accountability. Services can further be extended to include additional 
functionalities such as instant reporting, location based services, accountability, tracking and others.  
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CHAPTER 3: RESEARCH METHODOLOGY  
3.1  Introduction  
This section is concerned with the methodology of the software in development process of the prototype. 
The section is made up of key areas namely; Business Study, Feasibility Study, System Analysis and 
Design Methods, Implementation Methods, Testing and Evaluation Methods.  
  
3.2  Software Methodology  
The System Design method implemented was SCRUM which is an AGILE methodology. The nature of 
this study is highly emergent with a large populace. The methodology allows for flexibility in 
incorporating changing user requirements due to its incremental and iterative nature. Additionally Design, 
Implementation and Testing was done throughout the project lifecycle (Scrum, 2015).  
Figure 3.1 shows the steps involved in the SCRUM methodology process.  
  
Figure 3.1: SCRUM Methodology process  
   
SCRUM was chosen because of its useful agile practices such as Test-Driven Development (James, 2013). 
The entire application development process was involved in delivering business value. No discrepancies 
were there for made between the “business side” and “technical side”. Emphasis on decision making was 
done from real world results rather than speculation.  
The researcher incorporated three main roles namely the Product Owner, Scrum Master and the Team.  
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i) Product Owner: The researcher acted as the project/product owner with the vision, authority and 
was entirely available throughout the projects lifetime.  
ii) Scrum Master: The researcher acted partly as the Scrum Master through facilitation from the 
Supervisor. Impediments obstructing progress of the project were removed through frequent audits 
of the system flow by the researcher.  
iii) Team: According to the founder of SCRUM, the team is self-managing (Scrum, 2015). Here team 
members were responsible for self-organizing to complete work. The team comprised of the 
researcher as the main UI designer and programmer of the application, testers and other 
programmers who provided assistance when needed. The team had responsibility and autonomy 
to meet the goals of each sprint.  
  
3.2.1 Feasibility Study  
This is a trivial study done to aid in designing a further confirmatory study (Arnold , et al., 2009). A 
feasibility study was done through reviews of relevant literature on existing systems related to 
identification and verification of counterfeit drug items. The study was performed to analyse and evaluate 
the impending solution of the proposed system.  
  
3.2.2 Business Study  
 
Research Design  
To capture the full perspective of the research study a Descriptive research and Qualitative Research was 
done.  
i) Descriptive Research; this research type helped the researcher define the characteristics of the 
population in study. This provided a deeper understanding of interactions between the populace, 
drug items and the ability of the populace in identification of counterfeit drug items. The 
information acquired greatly influenced the decision on the technology to be adopted.  
ii) Qualitative Research; this research type was used to gain an understanding on views of the 
populace of the study in context to the area of study. The results from this research aided in 




Location of Study  
The study was done at a local supermarket for data collection within the County of Nairobi. The name of 
the Supermarket was Quickmatt located in Rwaka Township. Only one branch of the supermarket was 
visited. The area was selected for study due to easy access by the researcher and also due to its strong 
presence within the area of research.   
  
Target Population  
The target population was drawn from consumers or shoppers exiting from the retail store and willing to 
answer the researcher’s interview questions. Respondents were picked randomly as they exited the retail 
store.  
  
Sampling Strategy  
The researcher used Stratified Sampling technique. The stratum consisted of individuals leaving the retail 
store. These individuals were chosen as subjects to be interviewed for the study. This technique aided in 
focusing on the population that was most expected to interact with the proposed application.  
  
Sample Size  
25 respondents were interviewed daily for a span of 8 days. The total number of respondents interviewed 
was 200. This sample size also comprised of mixed gender, age, educational level and either employed or 
not. The sample size was deemed appropriate as it consisted of individuals that were highly likely to 
interact with drug items by purchasing directly from any retail store or chemist.   
  
Data Collection Procedure  
Different analytical tools were used to collect and analyse interviews and questionnaires namely: 
SurveyMonkey Analytical Tool for analyzing online questionnaires. Charts and bar graphs were used to 
provide clear visual presentations of responses. Below is a list of data collection methods that the 




i) Questionnaires; an online survey consisting of open and close ended questionnaires was 
administered to a targeted number of respondents. This was done as a Pre-Test analysis of the 
study to gain an understanding of how knowledgeable the study population was with regards to 
awareness of availability of counterfeit drug items in the market. The exercise was done through 
posting a set of questionnaire online. This enabled the researcher to know whether the population 
was in contact with other technologies used to identify and report existence of counterfeit items in 
the market. Data gathered was used to formulate requirements specifications.  
ii) Oral Interviews; Oral interview consisted of a set of questions that were performed individually 
to respondents to acquire user feedback on the developed prototype. Results were used to further 
refine the prototype.  
iii) Review of existing documentation; this involved the process of reviewing data by evaluating and 
analyzing existing documents. Documents reviewed by the researcher consisted of hard copy and 
electronic; reports, journals, newsletters, magazines, books, academic articles, texts and marketing 
materials.  
  
3.3  System Analysis and Design   
System analysis and design methods guided the researcher to understand what was needed to analyse data 
flow systematically, process data, store data and output information in context of the study (Kendall & 
Kendall, 2013).  
In selecting an appropriate methodology the researcher performed one on one interview using pre-defined 
questions that sought to understand the workings of current systems. Consideration was made on 
limitations of the system at the time of study to identify key user requirements. Outcomes from the 
interview greatly influenced results of the system analysis and design process. Through the concept of 
Object Orientation Analysis was done to ensure user requirements were modelled and analysed 
profoundly. Relationships of real world Objects were also identified.  
Unified Modelling Language (UML) was used as the modelling language. This aided in modelling 
analysis and design diagrams. Other than that the UML notation offered clarification to user requirements.  
Use - Case descriptions and diagrams were used to model system functionality. The System Sequence 
Diagram modelled the System Flow showing data passing between main entities of the system. Various 
entities with corresponding attributes and methods of implementation were modelled using Class 
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diagrams. The Entity Relationship Diagram was used to model the database. This showed the tables, 
attributes and relationships. The Database Schema modelled the table structure showing fields, data types 
and descriptions.   
Wireframes were later used to illustrate process flows of both the web and mobile applications. In both 
systems flow Adobe Illustrator CS6 was used as the designing tool.  
  
3.4  Prototype Implementation  
The prototype comprised of development of a mobile and web application connected to a central database. 
Below are approaches employed in the development of the applications:  
i) Mobile Application; the Operating System for the mobile application implementation was 
Android. The source code was written in Java, utilizing android classes. The application was 
compiled and tested using the android Software Development Kit (SDK) emulator and an android 
device. The application is optimized for android version 4.4.2 compatible with android devices on 
minimum version 2.0 and maximum version 4.4.4. JSON was used as the web service that provides 
the interface between the android application and the database. Reasons for choosing android as 
the client application include: flexible SDK, availability of Android Development Tools (ADT) 
and availability of abundant support from online developer communities.  
ii) Web Application; the web based application was developed using Hypertext Preprocessor (PHP). 
The website was hosted on an online Apache HTTP server. Reasons for using PHP were; it is an 
Open Source platform, it is platform independent; it supports all major webservers and databases; 
it has multiple layers of security to prevent threats and malicious attacks.  
iii) Database; the database was developed using the MySQL database. The reasons for using MySQL 
were; it is an open source platform; it is fully compatible with PHP and other platforms; it is secure 
in that all passwords are encrypted before storage restricting unauthorized access to the database.  
  
3.5  Evaluation of the Prototype  
The prototype underwent the following tests to find out whether it was in tandem with the specified goals 
of this dissertation:  
i) Functional Tests; functional and non-functional tests were performed on the prototype.  
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ii) Compatibility Tests; compatibility test were performed on different mobile and web-based 
applications on different Android based platforms and browsers respectively.  
iii) User Tests; this test was done on the developed application to measure user satisfaction and collect 
feedback for refining the prototype.   
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CHAPTER 4: SYSTEMS DESIGN AND ARCHITECTURE  
  
4.1  Introduction  
This section will provide a detailed explanation of the Design and Architecture of the proposed solution.  
Design diagrams were drawn under the unified Modelling Language (UML).  
  
4.2  Systems Analysis  
Systems Analysis is concerned with research findings of the study. Results were used to answer research 
questions evident in section 1.3 of this dissertation. The overall results contributed to design of the 
application through integration of various functionalities.  
  
4.2.1 Pre - Survey Analysis  
Prior to performing Systems analysis on the characteristics of the population a Pre-Survey analysis was 
performed. This analysis was done to maximise and justify the effectiveness and efficiency of the 
proposed application. This was done through holding brief interview sessions with the respondents. A 
copy of the questions can be found in the Appendices section under Appendix B. SurveyMonkey, an 
online Survey tool was used to set and analyse online questions that were emailed to a group of 28 
respondents. A copy of the questions can be found in the Appendices section under Appendix A.   
  
Figures 4.1 – 4.10 show the analysis of responses acquired from the online Pre-Survey Analysis questions.  




Figure 4.1: Feedback on Existence of Counterfeit Items  
Figure 4.1 indicates that all ten respondents encountered counterfeit drug items in the Kenyan market. 
This proves that existence of counterfeit drugs in the Kenyan market as a problem is real and in need of a 





Figure 4.2: Feedback on Identifying Counterfeit Items  
  
Figure 4.2 indicates that all respondents relied on human senses to detect legitimacy of drug items. 
Although many would agree that the above criteria for identifying counterfeit items can be perceived 
unreliable, it can only mean the lack of proper tools to perform such a task. Nine respondents answered 





Figure 4.3: Feedback on Existing Technology for Identifying Counterfeit Items  
  
Figure 4.3 indicates that all ten respondents answered this question. Nine respondents claimed to have 
never encountered any automated technology in the market used to identify existence of counterfeit drug 
items. It only proves that there is need to have a reliable automated system to help alleviate the problem 





Figure 4.4: Feedback on Media of Communication Used on any Existing Technology  
  
Figure 4.4 indicates that three respondents answered this question. The only electronically automated 
technology existing in the market is a software application accessible via a standalone desktop computer. 
The other controlled form of reporting encountered by respondents is the traditional paper and pen based 
process. In the current scenario development of a mobile based application would be the ideal solution to 




A total of 25 respondents were interviewed daily for a span of 8 days dispersed randomly in a month. The 
total number of respondents interviewed or Sample Size was 200 individuals. This group consisted of 
mixed gender groups, different ages and different socioeconomic status. The number of respondents who 
participated in the survey was 200 while the number of respondents who completed the survey was 187.  
The response rate therefore was 93.5%. This was calculated as:  
Response Rate = Number of respondents who completed the Survey/Total Sample Size  
(187/200) * 100 = 93.5%  
Questionnaires can be found under the Appendices section.    
  
4.2.2 Demographics  
A. Age Distribution of Shoppers  
Respondent’s ages were recorded to help the researcher find out age groups that were likely to frequent a 
retail store to purchase items. This aided in development of proper aesthetics customised for the larger 
population of the age group.  
 
Figure 4.5: Variations of the Different Age Groups  
  
Figure 4.5 shows the variation of the different age groups of the study group. This enabled the researcher 
to find out the age group of respondents that were actively shopping. This was to customize the developed 
application to the right age group. The findings indicated that majority of shoppers were aged 25- 35 years 
with a number of 96 respondents. 36-45 years were 41. The group of 15-24 years were 22, and the group 















B. Gender Distribution of Shoppers  
Respondent’s genders were recorded to help the researcher find out the gender population that was likely 
to visit a retail store to purchase items.  
  
 
Figure 4.6: Discrepancies between Genders  
  
Figure 4.6 shows discrepancies between genders of the study group. This study aided the research in 
identifying the actively shopping gender group to customize the developed application to suit majority of 
this population. It was evident that females formed majority of shoppers with a total of 112 compared to 
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41  
  
C. Marital Status of Shoppers  
  
 
Figure 4.7: Marital Status  
  
Figure 4.7 shows marital status of the study group. This aided the researcher in knowing whether the study 
population of shoppers was an audience geared towards a family unit. The developed application would 
then be customized to appeal to a broad range of users and not focused to individuals. Most of the shoppers 
were married persons.  
  
D.  Educational Disparities of the Shoppers  
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Figure 4.8 shows the education levels of the study population. This aided the researcher in determining 
whether users were individuals who could read instructions and follow simple gestures while using the 
developed application. The ability to read and write was deemed very important especially in cases where 
there was no human assistant to users of the application. Majority of the shoppers were people with 
educational level above form four level.  
  
E.  Employment Disparities of the Shoppers  
 
Figure 4.9: Employment Status  
  
Figure 4.9 shows the levels of employment for the study group. Majority of the shoppers were employed 
146 personnel out of the total 200. This showed the researcher that the population of study could get access 
to a data enabled phone proving the available large population of users for the potential mobile application.  
  
F.  Mobile Phone Usage and Service Experience  
Figure 4.10 shows the mobile phone use and service experience of the study group.The findings indicated 
that majority of shoppers have had mobile phones between 1-5 years and sent an average SMS of between 
25-50 per day as shown in figure 6. Moreover, majority of the respondents used data/INTERNET services 
for accessing social media activities and checking their personal or official mail. 3G/GPRS/WAP was 
used very often. An indication of growing culture of INTERNET usage and people possessing 










Figure 4.10: Mobile Phone Use and Service Experience  
  
4.2.3 Adaptation of Complex Features   
Majority disagreed strongly on using advanced features such as NFC (Near Far Communication), RFID 
(Radio-Frequency Identification) and some location based of their mobile phones. This guided the 
researcher to put into consideration the need to reduce complexity for the application use. They however 
agreed on using simple features such as taking photos and sharing them on social media. Moreover, they 
agreed strongly that simplicity of scanning products to verify their legitimacy would positively affect their 
decision of adopting it.  Majority of the respondents were of the opinion that they would be willing to 
follow 2-5 steps in order to complete a mobile device scanning process. Lastly, all respondents strongly 
disagreed that they would be reluctant to adopt the developed application if they had to pay a small fee 
for every scan.  
From the general questions asked to the respondents, majority strongly agreed that ease of use, 
convenience and efficiency would influence their decision of adopting the solution. Most respondents 
were also in agreement that remote mobile payments such as MPESA, MOBI-CASH and AIRTEL 
MONEY have been successful in Kenya, which can be attributed to the strong mobile industry and mobile 
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4.2.4 Results from data Collection and Analysis  
Following collection of data and analysis of results the researcher came up with the information below:  
• The proposed solution would be feasible for identifying and reporting the existence of illegitimate 
drug items in the Kenyan market especially in Nairobi.  
• It was evident that Android was the most popular and accessible operating system to majority of 
the populace. It was therefore the preferred platform for development of the application.  
• No technology was readily available and in use for identifying and reporting counterfeit drug items 
in the market. Existing technologies weren’t utilised by a majority of the populace.  
• From the results system requirements were formulated that aided in designing the system and in 
the implementation process.  
  
4.2.5 System Requirements  
A  Requirements Analysis  
This section outlines the Functional and Non- Functional requirements based on the user requirements 
collected alongside the initial study objectives.  
B  Functional Requirements  
These requirements define capabilities and functions that the implemented application or its components 
must perform successfully. They include a set of input, behaviour and outputs concurrent with objectives 
of the study, such as:  
i) Login/Logout; to gain access to the extra services such as viewing a history of all scanned items 
users are required to Login using a Username and Password. Users need to Logout to exit from 
the records.  
ii) View Scanned Items; users of the application should view the history or a list of products that they 
had previously scanned. iii) Report Scanned items; users of the application should be able to report 
on items that have been flagged as “not registered”.  




C  Non – Functional Requirements  
These are requirements that specify the criteria used to judge the operation of the system. They were 
contrasted in agreement with functional requirements that define specific behaviour or functions. They 
included:  
i) Performance; the system should have an acceptable response time while performing its functions. 
ii) Usability; the system should have an interface that is easy to use.  
iii) Integrity; the system being data oriented should ensure that data analyzed and stored is not altered 
or corrupted.  
iv) Security; the system should only allow authorized users to use its core functionalities.  
v) Reliability and availability - The system should be reliable and always available to perform tasks 
requested by the user.  
vi) Scalability; the system should be able to adopt additional functionalities. Additional data should 
be easy to incorporate.   
  
4.2.6 Level 0 Data Flow Diagram  
This data flow diagram shows the interaction between external entities and processes of the system. It also 
shows what kind of information will be input to and output from the system, data stores and where data 
will come from and go to (Burge, 2011).  
External entities of the system include:  
i) The Customer: the customer acquires information from the drug item by scanning it and posting 
it to a server. The customer can also view, review and rate chemists that he/she has interacted with. 
The customer can finally view details of drugs that have been previously scanned.  
ii) The System Administrator: the primary function of the System administrator is to manage data 
applications through adding, deleting and modifying information. In addition the admin can view 
details of the drugs purchased by the customers and their details.  
iii) Processes through which external entities interact include:  
iv) View drug information: provide detailed information of the drug purchased such as product name 
and generic name.  
v) Post location: provides the location of scanned drug items.  
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vi) View user/customer information: provides detailed information of users. Users must have 
registered to use the application at one point.   
vii) Report drug: counterfeit drugs can be flagged on the database. Action can be taken by agencies 
that have access to the database.  
    
Figure 4.11 shows the level 0 data flow diagram.  
  
Figure 4.11: Level Zero Data Flow Diagram  
  
4.2.7 Level 1 Data Flow Diagram  
Figure 4.12 represents a level 1 data flow diagram of the system. This highlights the systems main 
functions. The diagram expounds on processes experienced by key users of the system consisting of the 





Figure 4.12: Level One Data Flow Diagram  
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4.3  Systems Design  
The System Design will present the proposed solution in a logical manner using different Design 
diagrams.  
It will consist of six components:  
i) User Interface Flow Diagram  
ii) Use Case Diagrams/Descriptions 
iii) Sequence Diagrams  
iv) Partial Domain Diagrams  
v) Context Diagram  
vi) Level 0 Data Flow Diagram  
  
4.3.1 User Interface Flow Diagram  
This section deals with the flow of screen presentations when the user interacts with the application. On 
the applications first run a splash screen appears followed by the main menu screen. The main menu 
screen or home screen displays shortcuts to all functionalities of the application including a help menu 
button, login button and social media buttons. In this application a user has the option of accessing the 
settings menu; Login to view items scanned by the user and a social media portion.   
  
4.3.2 Use Case Diagram and Descriptions  
This is a behavioral diagram that shows the functionality provided by a system in terms of actors, their 
goals as represented by use cases and any dependencies on those use cases. The main actors of the system 
are the customers who purchase drugs and the system administrator. The main processes in this application 
are:   
i) Scan Drug Item; Primary actor is the customer who initiates the process of scanning drugs that 
he/she may want to purchase.  
ii) Report Drug Item; Primary actor is the customer/user who reports on an identified counterfeit drug 
item.  
iii) View Drug Item; Primary actor here is a user who can login and view the number of drugs used 
and details of the drugs he/she has used so far.  
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iv) Modify drug details; A systems administrator is the primary actor who adds, edits or deletes drugs 
from the database.  
Table 4.1: Use Case Description of the Application  
 
Use - Case  Description  
UC 1 - Scan Drug Item  i)  Primary Actor; Customer  
 ii)  Stakeholders:  
- Owner of the Chemist  
- Chemist attendant/Pharmacist  
 iii)  Preconditions:  
- User must have selected a drug  
- User must have purchased a drug  
 iv)  Success Scenarios:  
-  User can verify that a drug is genuine  
 v)  Frequency of occurrence  
-  Process occurs often  
UC 2 - Report Drug Item  i)  Primary Actor; Customer  
 ii)  Stakeholders:  
- Owner of the Chemist  
- Chemist attendant/Pharmacist  
 iii)  Preconditions:  
- User must have selected a drug  
- User must have purchased a drug  
 iv)  Success Scenarios:  
-  User can report that a drug is  
counterfeit  
 v)  Frequency of occurrence  
-  Process occurs often  
UC 3 - View Drug Item  i)  Primary Actor; Customer  
 ii)  Stakeholders:  
- Owner of the Chemist  
- Chemist attendant/Pharmacist  
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 iii)  Preconditions:  
- User must have selected a drug  
- User must have purchased a drug  
- User must have logged into the 
system  
 iv)  Success Scenarios:  
- User can view a list of all drugs purchased 
and scanned by the app  
 v)  Frequency of occurrence  
-  Process occurs often  
UC 4 - Modify Drug Details  i)  Primary Actor; System Administrator  
 ii)  Stakeholders:  
- Owner of the Chemist  
- Chemist attendant/Pharmacist  
 iii)  Preconditions:  
-  No Preconditions  
 iv)  Success Scenarios:  
- Details of the Drug can be edited  
- Users can view drug details  
 v)  Frequency of occurrence  
-  Process rarely occurs  
  
Table 4.1 shows the Use Case Description of the proposed mobile and web application. It comprises of 





Figure 4.13: An Illustration of the USECASE Diagram  
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Figure 4.13 shows an illustration of the Use Case Diagram with all Use Cases. The Use Cases describe 
sequences of actions providing some value to the actor and is represented as a horizontal ellipse. An actor 
is a person or an external entity, in this case, a person and a GPS server. Associations between Actors and 
Use Cases are indicated by use of solid lines with arrow heads pointing towards the direction of initial 
invocation of the relationship (UML 2 Case Diagrams: An Agile Introduction, 2014).  
  
4.3.3 System Sequence Diagram  
The system sequence diagram shows how users interact and receive feedback and messages to and from 
the system. It also shows how other activities in the system communicate i.e. from the applications 
interface and the database where information is added and retrieved. The diagram also shows how users 
receive feedback messages from the system. Major entities of the system sequence diagram were:  
i) The Customer: The customer scans drugs and verifies whether the drugs are genuine or counterfeit. 
The response from the server will be a confirmation message acquired by parsing through an 
identity list of drugs approved by a Quality Assurance body such as the Kenya Bureau of 
Standardisation (KEBS) or the Pharmacy and Poisons Board. Interactions between the customer 
and application also included viewer ratings and other reviews on posts from users.  
ii) The System Administrator: the primary function of the System administrator is to manage data 
applications through adding, deleting and modifying information.  
iii) The Software Application: both the system administrator and customer interact with the 
application.    
Figure 4.14 shows major entities communicating with each other in the systems sequence diagram. The 
system sequence diagram is used to show interactions between objects in the sequential order that 




Figure 4.14: System Sequence Diagram  
   
4.3.4 Partial Domain Diagram  
Figure 4.15 shows the partial domain diagram identifying relationships between entities of the application.  
A domain model is a visual representation of conceptual classes or real-situation objects in a domain 




Figure 4.15: Partial Domain Diagram  
  
4.3.5 Context Diagram  
A Context Diagram is a component of Functional Modelling that stands out on its own as a valuable tool. 
This allows for the production of a high level model of an existing/planned system defining the boundary 
of the system of interest and interactions with critical elements in its surroundings (Burge, 2011). A 
context diagram was used to represent actors outside of the system that directly interacted with the mobile 
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application. They consisted of entities and relationships. Entities represented the main system while 
multiple external entities represented external actors.  
Entities of the application included:  
i) Customers: these represented primary entities of the application ii) 
System Administrators: Manages application data  
Figure 4.16 shows relationships between entities representing flow of information through a context 
diagram.  
  
Figure 4.16: Context Diagram  
  
  
    
4.3.6 Database Schema  
A Database Schema is the skeleton structure that represents the logical view of the entire database. It gives 
a definition of how data can be organized and how the relations among them are associated (Database 
Schema, 2015). Figure 4.17 represent the Database Schema presented the logical view of the entire 




Figure 4.17: The Database Schema  
  
4.4  Systems Architecture  
The developed application implemented the Client Server Architecture. The client side consisted of the 
Android application that interact with GIS and GPS software modules embedded in the mobile device. 
User interacts with the application by scanning on items (drugs) purchased at a shop/pharmacy. Through 
an INTERNET connection the application verifies with the KEBS database to confirm whether the item 
scanned is genuine or counterfeit. If the item is genuine the user will clearly see the KEBS logo, a tick 
and the words “Genuine Product”. If the item is counterfeit the user will get a response with a large crosses 
mark “X”, with the words “Counterfeit Product”. The user will also have an option to report the item by 
pressing a button that will appear at the bottom of the screen. On pressing the button, information on the 
date, GPS location of the instance of scanning will be sent to the KEBS server.  
The application server verifies if the item scanned is genuine. It also collects feedback on location and 
date of scanning if an item has been reported as counterfeit. A system administrator has access to the 





Figure 4.18: Mobile Network Architecture  
  
Figure 4.18 shows the Mobile Network Architecture of the proposed system. This includes a mobile 
device, servers QR-Codes attached to drug items and a supporting mobile telecommunication service 
network such as SAFARICOM, AIRTEL and YU.  
    
 4.5   Mobile Application Wireframes  
Mobile application wireframes were used to give a visual guide presenting a skeletal framework of the 
application. They guided the researcher through arrangement of elements to achieve the goal of this 
research. Figures 4.19 and 4.20 show the wireframe designs of the Splash Screen and Login Screen 




Home Screen  
  
Figure 4.19: The Home Screen  
Report on Genuine Drug Item  
  





Uncertified Drug Item  
  
Figure 4.21: Report on 
Uncertified Item  
     
Feedback on successful report  
  




CHAPTER 5: SYSTEM IMPLEMENTATION AND TESTING  
5.1  Introduction  
This chapter constitutes implementation of the proposed application. Chapter 4 section 4.2.5 (B) gave the 
system functional requirements which the prototype functionalities incorporated.   
The implementation environment for the mobile application, web application and database will be 
described in this section to give a clear understanding of the actual implementation of the prototype. The 
implementation details provides descriptions of major system components and explanation of 
implementation procedures.  
The chapter also provides the system testing procedure. Tests performed were:  
i) Functional testing; where the system functionality was tested against the functional requirements. 
ii) Compatibility testing; where the applications were tested against different platforms and browsers.  
iii) Usability testing; which was conducted by potential users and their feedback analyzed.  
  
5.2  Implementation Environment  
5.2.1 Mobile Application Prototype  
The Operating System for the mobile application implementation was Android. The source code was 
written in Java, utilizing android classes. The application was compiled and tested using the android 
Software Development Kit (SDK) emulator and an android device. The application is optimized for 
android version 4.4.2 compatible with android devices on minimum version 2.0 and maximum version 
4.4.4. JSON was used as the web service that provides the interface between the android application and 
the database. Reasons for choosing android as the client application include: flexible SDK, availability 
of Android Development Tools (ADT) and availability of abundant support from online developer 
communities.  
  
5.2.2 Web Application  
The web based application was developed using Hypertext Preprocessor (PHP). The website was hosted 
on an online Apache HTTP server. Reasons for using PHP were; it is an Open Source platform, it is 
platform independent; it supports all major webservers and databases; it has multiple layers of security 




5.2.3 Database  
The database was developed using the MySQL database. The reasons for using MySQL were; it is an 
open source platform; it is fully compatible with PHP and other platforms; it is secure in that all passwords 
are encrypted before storage restricting unauthorized access to the database.  
  
5.3  Implementation Details  
5.3.1 The Mobile Prototype  
The prototype was designed to run on an Android Operating System device compatible with android 
devices with minimum version 2.0 and maximum version 4.4.4. The device running the application relied 
on an active INTERNET connection and a working camera. Full functionality of the application required 
interaction with a QR-Code reader and an application that managed data manipulation and interaction 
with a backend server.  
QR-Codes attached to drug items are captured by the mobile phone camera. A QR-Code reader 
application is used to analyse and generate a QR-Code number stored in the items QR-Code. The QR-
Code number then used as the unique identifier of a drug item.  
A unique QR-Code number is used to identify whether the item exists in the database or not. During an 
instance of scanning, the location of the device during a scan can be picked (this is only if the location 
service has been enabled) and stored in the database. Other information captured during a scan include; 
User information (if the user has logged into the application), time and date information. User experience 
was enhanced by providing functionalities in a simple but sleek manner. Also flow of the process was 
presented in a logical and easy way providing relevant data constraints in textboxes.  
  
Components of the system  
Some of the core components of the system are as follows:  
  
The Home Screen  
Figure 5.1 shows the Home Screen of the application. This is displayed upon launch of the application. 
A user doesn’t necessarily have to login to use the application but can proceed to scan items upon pressing 
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on “Scan Drug”. Users looking for more meaningful interaction with administrators of the system and to 
acquire feedback such as viewing a history of all drugs scanned will have to register and login in.  
 
Home Page  Home Page after Login  
    
Figure 5.1: Home Screen  Figure 5.2: Home Screen after Login  
    
Figure 5.2 shows a screenshot of the Home Screen after successful Login. The User Login interface 
allows a user to input his/her username and password. Users who may have lost their login credential 
have the option of resetting the username and password from this interface.  
Figure 5.3 shows a screenshot of the QR-Code Screen Capture. A user will scan directly onto a visible 









QR-Code Scanner Interface  Feedback on genuine drug item  
    
Figure 5.3: Screenshot of the QR-Code Scanner  Figure 5.4: Screenshot of Genuine Item Report  
 
Figure 5.4 shows a screenshot the feedback acquired upon scanning a genuine product. The product and 
generic name are shown with a mark of quality from KEBS.  
  
Feedback on scanning drug items  
Figure 5.5 presents a screenshot of the feedback acquired upon scanning a non-registered or counterfeit 
product. Details of the product don’t show the generic and product name since the product is alien to the 
database. The mark of quality from KEBS is also not visible. A user has the option of reporting an 
Uncertified or Unregistered drug item as in Figure 5.6.  
Figure 5.7 shows the feedback received upon successful reporting of an unregistered drug item. Figure 
5.8 shows a history of scanned drug items. Users can only view the items after successfully login into the 




Feedback on uncertified drug item  
  
Figure 5.5: Screenshot of Uncertified Item  
Reporting Interface  
  
Figure 5.6: Screenshot of Reporting Drug Interface 
 
 
Feedback after reporting drug item  
  
Figure 5.7: Screenshot on Successful Reporting  
  
View List of Scanned Items  
  
Figure 5.8: History of Scanned Items  
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5.3.2 Web Application  
The web application’s main function was to retrieve and receive information sent by the developed mobile 
phone application to the database. This application resides in the HTTP web server and is directly linked 
to the drug item’s management database. The web application was designed for use by administration to 
manage users, generate and view reports. The reports generated included: a report to view the number of 
registered users using the application; Scan location of registered users using the application; Number of 
scans performed by each registered user; Total number of scans performed by all registered users.  
  
System components  
The main components of administrative users of the Web Application components are:  
Administration Login  
To gain access to the web application system users have to login using a unique Username and Password.  
Once the Username and Password have been issued by the user, they are authenticated for protection.   
User Management  
This component offers user management roles. It allows an Administrator to View registered users 
scanning activities, to edit user profiles as activate and deactivate a user, View and edit location names of 
geographic coordinates picked by registered users who have used the application and to finally manage 
user levels. A screenshot of the User Management Interface is below.  
Scanned Drugs Report  
This component allows an Administrator to view details of all scanning activities in the system. It gives a 
report of the user and scan details including time of scan, location of scan, drug item scanned and whether 
the scanned item was registered or not.  
Registered Drugs Report  
This component allows an administrator to view details of all drugs registered in the system. They can 
edit, add and delete drugs through this interface. Figure 5.9 gives a screenshot of registered drug items 





Figure 5.9: Screenshot of Registered Drug Items in the Database  
  
5.4  System Testing  
5.4.1 Introduction  
This section describes tests performed on the mobile and web application. Tests were done against 
Functional and Non-functional requirements of the application.  
  
5.4.2 Functional Testing  
Functional tests were done based on use cases to determine success or failure of the system 
implementation and design. For each use case testing measures were set with results being considered 




Test Identifier 1: To Login or Logout  
  
Table 5.1: Test Identifier 1 (To Login or Logout)  
Utilised Use Case  Logging in or out of the system  
Test Parameters  Login with correct username and password pair/Logout  
Expected Behavior  Successful login and access granted/ Successful logout  
Observed Behavior  Successful login and access granted / Successful logout  
Test Outcome  Pass  
  
Table 5.1 shows results of test identifier one who’s main assessment was to check for correct login and 
logout functionalities of both mobile and web application. The observed and expected behaviour were 
consistent. Test Identifier one passed the trial and outcome was deemed successful.  
  
Test Identifier 2: To Scan a drug item  
  
Table 5.2: Test Identifier 2 (To scan a drug item)  
Utilised Use Case  Scan Drug Item  
Test Parameters  Expected response from server  
Expected Behavior  To successfully report that a scanned item is genuine or uncertified  
Observed Behavior  Successful report of both scenarios (genuine of uncertified product)  
Test Outcome  Pass  
  
Table 5.2 shows results of test identifier two whose main assessment was to check for correct behaviour 
and feedback from scanning a registered and non - registered drug item. The observed and expected 






Test identifier 3: To view a history of scanned items by a registered application user  
  
Table 5.3: Test Identifier 3 (View History)  
Utilised Use Case  View Scanned Items  
Test Parameters  A history of scanned items can only be viewed by a registered user  
Expected Behavior  Successfully view the history of scanned drug items by a user  
Observed Behavior  Successfully viewed a history of scanned drug items by a registered 
user  
Test Outcome  Pass  
  
Table 5.3 shows results of test identifier three whose main assessment was to view a history of already 
scanned drug items by a registered user. The observed and expected behaviour were consistent. Test 
Identifier three passed the trial and outcome was deemed successful.  
  
Test identifier 4: To view a list of scanned items by an administrator  
  
Table 5.4: Test Identifier 4 (View a list of Scanned Items)  
Utilised Use Case  View Scanned Items  
Test Parameters  Only scanned items by registered users should be visible  
Expected Behavior  Successfully list scanned items by registered users  
Observed Behavior  Successfully listed scanned items by registered users  
Test Outcome  Pass  
  
Table 5.4 shows results of test identifier four whose main assessment was to view a list of scanned drug 
items stored in the backend web interface by an administrator. The observed and expected behaviour were 





Test identifier 5: To Edit Users and User profiles  
   
Table 5.5: Test Identifier 5 (To Edit Users and User profiles)  
Utilised Use Case  Edit Profiles  
Test Parameters  Edit user profiles by administrator only  
Expected Behavior  Successful modification of user profiles by administrator  
Observed Behavior  Successfully modified user profiles by administrator  
Test Outcome  Pass  
  
Table 5.5 shows results of test identifier five whose main assessment was to edit users and user profiles. 
Observed and expected behaviour were consistent. Test Identifier five passed the trial and outcome was 
deemed successful.  
  
Test identifier 6: Modify Drug Details  
   
Table 5.6: Test Identifier 6 (Modify Drug Details)  
Utilised Use Case  Modify Drug details  
Test Parameters  Drug Details can only be modified by an administrator  
Expected Behavior  Successfully modification of scanned drug items  
Observed Behavior  Drug details can be successfully modified by and administrator  
Test Outcome  Pass  
  
Table 5.6 shows results of test identifier six whose main assessment was to check for the ability to modify 
drug item details by an administrator. The observed and expected behaviour were consistent. Test 






Test identifier 7: Modify the location name of coordinates picked from a scan  
   
Table 5.7: Test Identifier 7 (Modify Location)  
Utilised Use Case  Modify Scanned location name  
Test Parameters  Location name from scan coordinates can only be modified by a 
system administrator  
Expected Behavior  Successful modification of location name picked from scan 
coordinates modified by a system administrator  
Observed Behavior  Location name from a scan coordinate modified by the system 
administrator only  
Test Outcome  Pass  
  
Table 5.7 shows results of test identifier seven whose main assessment was to modify the location name 
of coordinates picked from a user’s scan location. The observed and expected behaviour were consistent.  
Test Identifier seven passed the trial and outcome was deemed successful.  
  
5.4.3 Compatibility Testing  
Compatibility was done to ensure that the mobile and web applications were compatible with the available 
platforms. The mobile application was tested against the predefined available Android platforms while 




Compatibility Testing on the Android Platform  
The table 5.8 shows tests conducted on predefined and locally available Android platforms.  
 
Table 5.8: Predefined Available Android Operating System Platforms  
Android Platform  Compatible  
Android 5 (2.0)  Yes  
Android 8 (2.2)  Yes   
Android 9 (2.3.1)  Yes   
Android 10 (2.3.3)  Yes  
Android 11 (3.0)  Yes  
Android 12 (3.1)  Yes  
Android 13 (3.2)  Yes  
Android 14 (3.3)  Yes  
Android 15 (4.0.3)  Yes  
Android 16 (4.1.2)  Yes  
Android 17 (4.2)  Yes  




Web Browser Testing  
The table 5.9 shows testing done on available and commonly used web browsers.   
 
Table 5.9: Test done on Available Browsers  
Browser types  Compatibility  
INTERNET Explorer (versions 4 and 
above)  
Yes  
Firefox (version 8.0 and above)  Yes  
Chrome (All versions)  Yes  
  
5.4.4 Usability Testing  
End users of the application were involved in usability testing. This group defined the target population 
available to use the system. A total of 36 respondents carried out the user testing practice giving 
appropriate feedback for the research. 36 respondents were used as these were the only individuals who 
created time to visit a stand and participate in the process of scanning. User testing was done to achieve 
the following objectives:  
i) User friendliness 
ii) functionality  
iii) Aesthetics  
iv) Acceptance  
This section will focus on each of the mentioned objectives in detail. The findings will be presented 
graphically for an elaborative visual presentation.  
  
User Friendliness  
78% of the potential users indicated that the application was easy to use and learn. They managed to use 
the application without prior training. 12 % of the respondents found the application fair to use meaning 
it was neither easy nor hard to learn and user, they needed the intervention of a trainer in some cases to 
confirm that what they were doing was right. 10% of the respondents found that application difficult to 
use. These were individuals who had just acquired a data enabled device. Others claimed to have used the 
phone camera for another use from the norm which was to scan on a QR-Code and note take a picture!  




Figure 5.10: Test Results on User Friendliness  
  
Functionality  
Users of the application tested system functionality to verify whether they responded to their expectations. 
75% of the respondents indicated that the applications functionality was commendable. 15% of the 
respondents indicated that the functionality was average meaning that some functional aspects of the 
application weren’t satisfactory. 10% of the respondents indicated that the systems functionality did not 
meet its intended goal. The overall result collected was used to refine the application up to the level of 










Figure 5.11: Test Results on Functionality of the Mobile Application  
  
Aesthetics  
User interface aesthetics is defined by the look and feel of the application design and flow to its users. 
84% of the respondents indicated that the application had an attractive presentation. 14% of the 
respondents indicated that the application was acceptable while the remaining percentage indicated that 
the application was not pleasing to the eyes. A summary of the results can be viewed in Figure 5.12.  
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The acceptance test was done to find out whether the application can be incorporated for use by its target 
users. 88% of the respondents found the application useful. 6% of the respondents were reluctant in 
accepting the application while the remaining 5% would not use the application. A summary of the result 
can be viewed in Figure 5.13.  
 
Figure 5.13: Test Results on Acceptance  
 
Below are responses from the Survey in relation to the research questions:   
There was evidence of the existence of counterfeit items in Kenya: a majority of the respondents felt that 
counterfeit/uncertified drugs items were in distribution all over the country. Respondents felt that having 
stickers with a mark of quality assurance from KEBS attached to products gave them confidence on 
legitimacy of products but were skeptical about sources of the sticker.  
Effects of consuming uncertified drug items were evident: a majority of users claimed that consumption 
of drug items that were perceived not to be genuine hardly solved medical problems intended for. Money 
seemed to be wasted on such drugs.  
There was no evidence of the existence of any technology that the public could use to identify and report 
existence of counterfeit drug items: Majority of the respondents were not aware of any technology that 
they could use to identify and report the existence of genuine and counterfeit products in the Kenyan 






Accepted Hesitant Rejected 
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The mobile application was beneficial for its intended purpose: From the usability testing 78% of the 
respondents indicated that the application was user friendly in that it was easy to learn and use. 75% of 
the respondents indicated that the applications functionality was commendable. In terms of aesthetics 84% 
of the respondents indicated that the application had an attractive presentation and finally 88% of the 
respondents found the application useful and acceptable.  
  
5.5  Summary  
Fundamental information used in the system implementation stage was provided by system requirements 
formulated in the requirements gathering and analysis stage. Research objectives and questions were also 
put into consideration in ensuring that the system was implemented to achieve user requirements provided 
by targeted users.  
The overall project adhered to a majority of the proposed objectives. The research was completed in ample 
time for testing and getting feedback from the application. The mobile application was developed to run 
on the Android platform. The mobile application consisted of a QR-Code reader and an inbuilt system for 
information recording and display. The web based application was developed entirely for user 
management, data generation, data reporting and data manipulation.  
System testing was done in three phases: Functionality Testing; was done to ensure user requirements 
were met, Compatibility Testing; was done to test the mobile application to the Android platform and the 
web based application to web browsers, User Testing; was done to test User Friendliness, Application  
Functionality, Interface Aesthetics and User Acceptance of the prototype.     
77  
  
CHAPTER 6: DISCUSSION OF RESULTS FROM THE TESTING  
6.1  Introduction  
The research was done with the aim of investigating current technologies that have been implemented to 
try and systematically identify and report counterfeit or uncertified drug items. An appropriate technology 
was therefore identified and developed from the research findings. The technology comprised of a mobile 
and web based application. The mobile application was strategically developed for use by the general 
populace who had access to a data enabled phone with a camera and running an android operating system. 
The web application was developed for management by administrators and could be accessed using a 
standalone computer, laptop or mobile device. This chapter describes research findings and achievements, 
how research objectives were obtained and provides a review of the application developed citing 
advantages and limitations of the developed application.    
  
6.2  Findings and Achievements  
Kenya has no systematic method of identifying and reporting suspected drug items. Drugs can be traced 
in the market after reports of having substandard value or observation, while others are encountered in the 
course of quality control. The literature review pointed out some of the techniques that have been used 
internationally and locally to help identify and report on uncertified or counterfeit drugs. The techniques 
include the use of technologies such as RFID, SMS and QR-Codes.  
RFID application is a reliable technology in identifying and tracking items in large organization having 
enormous supply chain management systems. Considering the region of research, it would be too 
expensive a venture to follow. The RFID chips and readers are expensive when considering that each drug 
item needs to tagged with a unique RFID chip.  
SMS application is an expensive and so far the predominantly used technology to check the legitimacy of 
drug items by the public in emerging markets such as Africa, the Middle East and Asia. Multinational 
drug companies such as GlaxoSmithKline and Bayer Pharmaceuticals own the biggest market share in the 
manufacture and distribution of drug items in such markets. This gives these companies the financial 
muscle to implement such systems with ease restricting implementation by local manufacturers. SMS 
based applications are also limiting in that they are restricted in interactivity with users.  
The use of QR-Codes emerging as the next best technology to advertise and collect other information such 
as market behavior towards certain products in the market. With the availability of data enabled mobile 
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devices cheaply to the public, the use of QR-Codes will be the preferred technology for automatic 
identification and data capture. The technology proves to be simple, universal and affordable to use and 
implement.   
The research was carried out outside a local supermarket in Nairobi County. The target population for this 
study were consumers who shopped at a local supermarket, QuickMatt supermarket located in Rwaka 
Township, Nairobi. A total of 25 respondents were interviewed daily for a span of 7 days. The total 
number of respondents interviewed were 175 individuals. The local supermarket was selected because of 
its strong presence within the area of research.  
  
The findings indicated that majority of shoppers were aged 25-35 years with a number of 96 respondents. 
36-45 years were 41. The group of 15-24 years were 22, and the group of 46-55 years were 27 and finally 
56+ were 14. Additionally, females formed majority of shoppers with a total of 112 compared to 88 for 
men. Moreover, most of the shoppers were married persons and also who were employed. A high number 
of respondents with data enabled mobile devices were found to own devices that run on the Android 
Operating system. Lastly, majority of the shoppers were people with educational level above form four 
level.  
The findings collected from the research led to the development of a mobile based solution used to identify 
and report existence of counterfeit or uncertified products by scanning QR-Codes attached to them. The 
registering body in this case was the Kenya Bureau of Standards. The technology comprised of a mobile 
and web based application. The mobile application was strategically developed for use by the general 
populace who had access to a data enabled phone with a camera and running an android operating system. 
The web application was developed for management by administrators and could be accessed using a 
standalone computer, laptop or mobile device.  
Cumulative research findings indicated that a majority of the users found the application beneficial for its 
intended purpose. From the usability testing 78% of the respondents indicated that the application was 
user friendly in that it was easy to learn and use. 75% of the respondents indicated that the applications 
functionality was commendable. In terms of aesthetics 84% of the respondents indicated that the 
application had an attractive presentation and finally 88% of the respondents found the application useful 




6.3  Review of Research Objectives in Relation to the Mobile Application  
Research objectives acted as guidelines to developing the mobile and web application.  
The first objective was to investigate the prevalence of counterfeit drug in Kenya and internationally. This 
was achieved by review of relevant literature from other countries on the effects of counterfeit drugs to 
the economy and population. The study showed that all countries experience the problems of dealing with 
counterfeit products. Governing bodies in countries play the leading role in regulating the importation, 
manufacture and distribution of such products to their population. Third world countries were most 
affected by infiltration of counterfeit products in their markets due to weak legislative laws. Governments 
in these regions were at task to ensuring that there was proper control of legitimate drugs within their 
borders. Locally it was identified that there was no systematic way of identifying counterfeit/registered 
drugs. Usually drugs would be traced in the market after reports of having substandard value, by observing 
the drug physical appearance, while others were encountered in the course of quality control. All in all 
the objective created a need to have a solution to alleviate the problem of dealing with counterfeit products.  
The second objective which was to investigate current technologies used to track and report existence of 
genuine and counterfeit products in the market aided in giving the researcher an understanding of 
techniques that are already used in the market. Strengths and weaknesses were identified for each 
technique and the best was chosen for adoption. Techniques used included the use of SMS based 
applications and serial numbers attached to drug items, use of RFID tags attached to drug items and finally 
the use of QR-Codes attached to the drug items. Based on the literature review, the use of QR-Codes 
emerged as the most efficient, reliable and current technique for implementation of the solution to the 
problem.  
The third objective was to develop a mobile based application that can give information on genuine 
products and flag counterfeit products in the market through the use of QR-Codes. This was achieved 
through the design and implementation of a mobile application with a web application for administrative 
management of products and user responsibilities. The mobile application was developed to run on the 
Android Operating system while the web application was developed using PHP and MySQL.  
The final objective which was to test the effectiveness and efficiency of the developed mobile application 
was achieved by doing different kinds of tests. Functional testing was done to test how operable the system 
was, compatibility testing was done to ensure that the application performed at its optimum on a variety 
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of Android versions with the web application tested on a variety of web browsers. Usability testing was 
finally done which confirmed user friendliness, aesthetics, user acceptance and functionality.  
 
6.4  Review of the Application in Relation to Current Drug identification 
Techniques  
The prototype was designed to run on an Android Operating System device compatible with android 
devices with minimum version 2.0 and maximum version 4.4.4. The device running the application 
needed INTERNET connection and a working camera. Full functionality of the application required 
interaction with a QR-Code reader and a records management application.  
QR-Codes attached to drug items are captured by the mobile phone camera. A QR-Code reader application 
was used to analyse and generate a QR-Code number stored in the items QR-Code. The QR-Code number 
then used as the unique identifier of a drug item. A unique QR-Code number was used to identify whether 
the item existed in the database or not. During an instance of scanning, the location of the device during 
a scan was be picked and stored in the database. Other information captured during a scan included; User 
information (if the user has logged into the application), time and date information.   
SMS application is an expensive and so far the predominantly used technology to check the legitimacy of 
drug items by the public in emerging markets such as Africa, the Middle East and Asia. Due to their high 
cost implementation was biased to a few multinational companies. SMS based applications were also 
limiting in that they were quite restricted in interactivity with users.  
  
6.4.1 Advantages of the Application  
Some of the advantages of the application in relation to current ways of identifying legitimate and 
counterfeit drugs in the market included the following:   
i) Information about legitimate drugs registered by a standardization 
body such as KEBS was easily accessible. 
ii) The application offered accuracy of information captured and retrieved. 
iii) The application was real-time. 
iv)  Reporting was instantaneous.   
v) Users who have logged into the system have a view history of drugs they have scanned.  
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vi) More information can be acquired from the application such as market behavior on the use of 
different drugs by the population.  
vii) The application incorporates a web application that can be used for data manipulation and data 
representation.  
viii) Reporting is location based thereby giving insight into the origin of drugs purchased by the 
population.  
  
6.4.2 Limitations of the Study  
The study has offered an evaluative perspective on an important national development strategy in fighting 
against counterfeiting of products. This has been achieved technologically by development of a mobile 
and web based application that identifies and reports existence of counterfeit products in Nairobi County, 
Kenya. Although this research was carefully prepared, limitations were encountered that have been 
highlighted below.  
i) The application was biased towards users with mobile devices running on the Android Operating 
system. This greatly limited responses to a few selected individuals from an already downscaled 
populace. ii) The application requires the use of only data enabled phones with an embedded camera. 
INTERNET availability is mandatory for the application to run. Respondents with feature phones that 
without INTERNET connectivity and lacking an embedded camera were automatically disqualified 
from the exercise. This negatively affected prospective worthy responses from the populace.  
iii) The application is independent of the cost of printing QR-Codes. This entirely leaves the cost of 
printing QR-Codes at the hands of sellers of drug items. This could negatively affect the exercise 
if sellers become unwilling to print and attached QR-Codes to specific drug items due to extra 
costs in printing.  
iv) It was assumed that feedback from respondents was genuine and not biased. The researcher did 
not consider the socio-economic level of respondents as a criteria for allowing an interviewee to 
participate in the interview session.   
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CHAPTER 7: CONCLUSIONS AND RECOMMENDATIONS  
This chapter presents the conclusions of the research described in this dissertation. The aim and objectives 
of the dissertation, outlined in Chapter 1, are reviewed and their achievements addressed.  
Proposals for future work indicated by the dissertation are suggested.  
  
7.1  Conclusions  
The study was set out to explore on the prevalence, use and effects of counterfeit or uncertified drug items 
to the population in emerging or third world markets. This was coupled up by development of a Data 
Driven Mobile Phone Solution for Systematically Identifying and Reporting non-Standardised Drugs in 
Nairobi County, Kenya. The study also sought to know whether developed mobile application would be 
efficient in solving the stated problem and would be accepted by the population of the research study. The 
general theoretical literature on this subject in the context of Kenya is conclusive on successful 
implementation and use of the developed application as a tool for identifying and reporting existence of 
counterfeit/uncertified drug items. It is however inconclusive in the implementation of certain laws that 
ensure local and international manufacturers register each distributed item under a government quality 
assurance body such as the KEBS.   
The developed application was aimed at ensuring: easy verification of the authenticity of drug items in 
the market, improve accuracy in drug items information, creating a sense of responsibility to the populace 
and reviewing drug items purchased by users.  
System testing was performed, look and feel, ease of use, system functionality and acceptance was done.  
  
7.2  Recommendations  
Below is a list of recommendations of the developed application to other stake-holders such as 
governmental and non-governmental organizations that may use the application. Some of these 
organisations include the Pharmacy and Poisons Board or KEBS, health facilities at national, county, 
sub-county and local levels.  
i) The government should adjust policies on drug items that direct local and multinational companies 
to register with quality assurance bodies in the country. This should enable manufacturers and 




7.3  Suggestions for Future Research  
The weaknesses and limitations of the proposed solution in the research study have indicated the following 
areas as recommendations for further work.  
ii) The application should be developed to run on other platforms other than Android to incorporate 
users using phones running on different Operating Systems.  
iii) The mobile application should be further developed to allow for persistent storage of data captured.  
This capability will make it possible for a user’s mobile device to store data when there is no 
INTERNET connectivity. Data can then be transmitted to the server and response back to the 
mobile device immediately an INTERNET connection is established.  
iv) There should be future research work done on how the mobile and web application can be 
integrated with other financial systems and Enterprise Resource Planning software.  
v) Loyalty point’s equivalent to financial rewards can be appended to the system upon use by 
consumers. Rewards should be awarded after reporting of counterfeit/uncertified items. This in 
effect will encourage more interaction between users and the system.  
vi) More functionality should be added to the web application to analyse market behaviour of the 
population’s use of specific drugs.  
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B: INTERVIEW QUESTIONS  
1. What is your Age?   
2. What is your Gender?   
3. What is your marital status Marital Status?   
4. What is your education level?    
5. What is your employment status?   
6. How long have you owned a mobile phone, in years?   
7. How many SMSs do you send per day?   
8. Do you use any data enabled (e.g. Check email, play online games, WhatsApp) services?  
9. Your frequency of 3G/GPRS/WAP use?  
10. What operating System does your phone run on?   
11. How many Data enables application services do you use?   
12. Your frequency of using individual data application services weekly?   
13. The average amount of time you spend using Data application services per week?   
14. Your frequency of INTERNET usage?   
15. Your frequency of mobile shopping services use?   
16. Do you use most of the advanced features on your mobile phone/device?   
17. How does the simplicity of using a mobile device to scan over a QR-Code affect your 
decision to adopt its use?   
18. How many steps would you be willing to follow in order to confirm whether a product that 
you want to verify is legit or compromised?   
19. Would you still adopt a mobile device scanning procedure to verify legitimacy of products 
even if you had to pay a premium for every transaction?   
20. Would the ease-of-use associated with the developed application influence your decision 
to adopt the solution?   
21. Would the convenience associated with the developed application influence your decision 
to adopt the solution?   
22. Would the efficiency associated with developed application influence your decision to 
adopt the solution?  
23. What is your current position?  
24. How long have you worked in this position?  
90  
  
25. Do you think scanning of products to verify their legitimacy has been successful in  
Kenya? [Yes] [No]  
26. Have you ever heard of the term QR-Code? [Yes] [No]  
27. Is there a need for scanning products using mobile devices to verify the legitimacy of 
products? [Yes] [No]  
28. Do you feel that the attributes Convenience, Ease-of-use and efficiency have affected 
mobile service adoption in Kenya? [Yes] [No]  
29. What trust and security concerns do you think might affect consumer adoption of data 
enabled services?  
30. Do you think consumers would rather use a trusted mobile device application to verify the 
legitimacy of a product rather than an attached paper stickers from a recognized body? [Yes] [No]  
31. Have you ever encountered a mobile or standalone application that can be used to help 
identify and report any counterfeit product in the market? [Yes] [No]  
32. Have you ever used any mobile device application to help you identify and report 
counterfeit products in the market? [Yes] [No]  
33. What is your confidence level on the legitimacy of products you purchase that have been 
tagged with the KEBS sticker?  
- Very confident  
- Slightly confident  
- Not sure  
- Don’t care  
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E: List of System Users Wireframe  
  
   





























A summary report on the number of drugs in the system server  
  
A summary report on the number of reported drugs by users in the system server  
  
A summary of the number of administrators in the system server  
  
A summary of the number of users in the system server  
 
  
A menu list of links to items in the system server  
  
Top menu pane that allows a user to login and logout of the backend system  
  
Title pane that shows a user the title of the current page. This is associated with the active 
link on the menu list  
  























Product category table  
  
  











G: TURNITIN REPORT  
  
  
